TR201001902A2 - Trimetazidine tablets with extended release - Google Patents

Trimetazidine tablets with extended release

Info

Publication number
TR201001902A2
TR201001902A2 TR2010/01902A TR201001902A TR201001902A2 TR 201001902 A2 TR201001902 A2 TR 201001902A2 TR 2010/01902 A TR2010/01902 A TR 2010/01902A TR 201001902 A TR201001902 A TR 201001902A TR 201001902 A2 TR201001902 A2 TR 201001902A2
Authority
TR
Turkey
Prior art keywords
trimetazidine
tablets
extended release
trimethaside
prepared
Prior art date
Application number
TR2010/01902A
Other languages
Turkish (tr)
Inventor
Bulgur Abdullah
Original Assignee
Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2010/01902A priority Critical patent/TR201001902A2/en
Priority to PCT/TR2010/000173 priority patent/WO2011112160A1/en
Publication of TR201001902A2 publication Critical patent/TR201001902A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Polietilen oksit polimeri kullanılarak direk baskı yöntemi ile hazırlanmış Trimetazidin kontrollü salınım formu ile ilgilidir Formülasyon sindirim sisteminin pH aralığında sabit bir salınım profili venr ve safsızlıklar açısından stabilize edilmiştirThe formulation relates to a controlled release form of trimethaside prepared by direct printing using polyethylene oxide polymer.

TR2010/01902A 2010-03-12 2010-03-12 Trimetazidine tablets with extended release TR201001902A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/01902A TR201001902A2 (en) 2010-03-12 2010-03-12 Trimetazidine tablets with extended release
PCT/TR2010/000173 WO2011112160A1 (en) 2010-03-12 2010-09-01 Extended release trimetazidine tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/01902A TR201001902A2 (en) 2010-03-12 2010-03-12 Trimetazidine tablets with extended release

Publications (1)

Publication Number Publication Date
TR201001902A2 true TR201001902A2 (en) 2011-04-21

Family

ID=43244791

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/01902A TR201001902A2 (en) 2010-03-12 2010-03-12 Trimetazidine tablets with extended release

Country Status (2)

Country Link
TR (1) TR201001902A2 (en)
WO (1) WO2011112160A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102885795A (en) * 2012-10-31 2013-01-23 广州帝奇医药技术有限公司 Trimetazidine dihydrochloride sustained-release tablet and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625055B2 (en) 1985-03-18 1994-04-06 日本ケミフア株式会社 Persistent tablets
FR2717687B1 (en) 1994-03-24 1996-06-14 Adir Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.
FR2802424B1 (en) 1999-12-17 2002-02-15 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
EP1195160B1 (en) 2000-10-05 2009-09-16 USV Ltd. Sustained release trimetazidine pharmaceutical compositions and a method of their preparation
WO2003043610A2 (en) 2001-11-21 2003-05-30 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
WO2009066315A2 (en) * 2007-08-08 2009-05-28 Usv Limited Sustained release compositions of trimetazidine and process for preparation thereof
EP2200591A2 (en) 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine

Also Published As

Publication number Publication date
WO2011112160A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
DOP2014000203A (en) HETEROCICLYL COMPOUNDS
ECSP14027269A (en) MACROCYCLIC PICOLINAMIDES AS FUNGICIDES
TR201909389T4 (en) Process for preparing therapeutic nanoparticles.
MY172156A (en) Modulators of methyl modifying enzymes, compositions and uses thereof
TR201903569T4 (en) A delayed release drug formulation.
MX2013006034A (en) Compounds capable of releasing fragrant compounds.
FR2997562B1 (en) BIPOLAR PLATE FOR FUEL CELL
AR085482A1 (en) COLORING POLYMER
CR20120033A (en) DERIVATIVES OF 5-FLUORO-2-OXOPIRIMIDINA-1- (2H) CARBOXYLATE.
PH12014501240A1 (en) Film containing compositions
EA201300733A1 (en) RECOMBINANT MICOBACTERIA AS A VACCINE
MX340436B (en) Stable pharmaceutical formulation with limited discoloration.
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
TR201202948A2 (en) Tablet formulation comprising dapaglyphlosin and prolonged release metaphormin.
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
TR201100150A2 (en) Water soluble dosage forms
PH12015501390A1 (en) Tablets with improved acceptance and good storage stability
FR2985382B1 (en) FUEL CELL
FR2997561B1 (en) BIPOLAR PLATE FOR FUEL CELL
TR201001902A2 (en) Trimetazidine tablets with extended release
TR201100148A2 (en) Stable acarbose formulations.
MX337237B (en) High bulk tissue comprising expandable microspheres.
FR2997229B1 (en) IMPROVED FUEL CELL
TR201109159A2 (en) Film-coated tablet composition containing eplerenone.
PH12016501056A1 (en) Film forming containing compositions comprising polyvinyl acetate and a pigment